文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 医药卫生 > 具有细支气管肺泡癌特征肺腺癌与其他类型腺癌的对比分析_英文_
侵权投诉

具有细支气管肺泡癌特征肺腺癌与其他类型腺癌的对比分析_英文_

Comparative analysis of lung cancer with features of

bronchioloalveolar carcinoma and other types of adenocarcinoma*

Leina Sun, Yan Guo, Zhongli Zhan, Baocun Sun, Na Dong, Ankang Gu, Huanling Luan

Department of Pathology, Tianjin Medical Universit Cancer Institute and Hoapital, Tianjin Key Laboratory of Cancer Prevention; Tianjin Diagnosis and Therapy Cancer of Lung Cancer, Tianjin 300060, China

Received: 29 October 2009 / Revised: 5 December 2009 / Accepted: 25 December 2009© Springer-Verlag Berlin Heidelberg 2010

Abstract Objective: The aim of this study was to investigate the clinicopathologic and prognostic factors of the partial subtypes of lung adenocarcinoma, including pure bronchioloalveolar carcinoma (BAC), adenocarcinoma (AC) with BAC com-ponent and AC without BAC component. Methods: One hundred and six adenocarcinoma specimens which were followed up completely for 3 years, were obtained from 106 patients (45 men and 61 women) who underwent surgical resection for pathologically confirmed pulmonary adenocarcinoma in the Cancer Hospital of Tianjin Medical University, from June 2004 to December 2005. According to the recent 2004 World Health Organization (WHO) pathological classification criteria of lung cancer, lung adenocarcinomas were divided into three subgroups: pure BAC, AC with BAC component and AC without BAC component. The clinical data were retrospectively analyzed based on statistical methods. All data were analyzed using SPSS statistics software and Kaplan-Meier survival curves were constructed, meanwhile, we conducted a Log-rank test. Results: The statistical analysis showed that no significant association was found among the three groups in gender and age; however, smoke index, tumor size, N stage, TNM stage, postoperative recurrence and metastasis had a statistically significant correla-tion among three groups (P < 0.01). The 3-year survival rates of the three groups were 96.4%, 61.0% and 40.5% respectively, which had a statistically significant difference. And the 3-year survival rate was significantly higher in the patients with pure BAC than in the patients with other types of lung adenocarcinomas (P < 0.01). In contrast to the other two groups (pure BAC and AC with BAC component), we found the evidence that the 3-year prognosis of lung adenocarcinoma without BAC com-ponent was worse than the two formers. Conclusion: The three groups (pure BAC, AC with BAC component and AC without BAC component) have their own distinct clinicopathologic features respectively and completely different clinical prognosis. The strict distinction of the subtypes of lung adenocarcinoma can provide more reliable basis for scientific and comprehensive clinical treatment and contribute to assess the clinical prognosis effectively.

Key words lung cancer; adenocarcinoma (AC); bronchiolo-alveolar carcinoma (BAC); prognosis

The incidence of lung adenocarcinoma is showing a rising trend transparently. At present, it already has been the most frequent histological type of lung cancer in many countries. Its morphological heterogeneity is very common which often mixed with different types of component. Pure BAC accounts for non-small cell lung cancer (NSCLC) 2%–5%, but AC with BAC component in NSCLC is up to 20%. Because of its individuality of molecular biology, pathology, radiology, treatment and so on, BAC has been focus on by lots of researchers. In recent years, it has been shown that the biological char-acteristics of BAC is different from other types, which is

Correspondence to: Zhongli Zhan. Email: hyunsungsun@yahoo.com.cn* Supported by a grant from the National Nature Sciences Foundation of China (No. 30770828).

better than the laters [1]. It was rarely reported that the differences between pure BAC and AC with or without BAC component. We collected clinical information of pa-tients with lung adenocarcinoma who underwent surgi-cal resection and classified them into three groups: pure BAC, adenocarcinoma with BAC component and adeno-carcinoma without BAC component based on the 2004 World Health Organization (WHO) classification. Then we make a retrospective analysis about their clinicopath-ologic significance.

Materials and methods

Patients and tumors

Tumor samples from patients with primary lung ad-enocarcinoma were obtained from 106 randomly selected

第1页

你可能喜欢

热门文档

相关文档

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email